scholarly journals Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent

2021 ◽  
Vol 6 (1) ◽  
pp. 1-99
Author(s):  
Robert S. Danziger ◽  
John T. Scott
Keyword(s):  
Technology Transfer ◽  
Public Funding ◽  
Coronary Stent ◽  
Drug Eluting

scholarly journals Drug-eluting coronary stent “Ultimaster®”

2016 ◽  
Vol 31 (3) ◽  
pp. 235-240
Author(s):  
Noboru Saito ◽  
Hiroaki Nagura ◽  
Yoshitaka Oomura ◽  
Kazuhito Ishihara
Keyword(s):  
Coronary Stent ◽  
Drug Eluting

scholarly journals Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

2008 ◽  
Vol 264 (5) ◽  
pp. 472-480 ◽  
Author(s):  
N. Sarafoff ◽  
G. Ndrepepa ◽  
J. Mehilli ◽  
K. Dörrler ◽  
S. Schulz ◽  
...  
Keyword(s):  
Stent Placement ◽  
Oral Anticoagulation ◽  
Coronary Stent ◽  
Drug Eluting

scholarly journals Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis

2018 ◽  
Vol 11 (10) ◽  
Author(s):  
Mithun J. Varghese ◽  
Samit Bhatheja ◽  
Usman Baber ◽  
Safwan Kezbor ◽  
Aditi Chincholi ◽  
...  
Keyword(s):  
Coronary Stent ◽  
Stent Restenosis ◽  
Intravascular Brachytherapy ◽  
Drug Eluting

Abstract 116: Is There Gender Disparity in the Use of Drug Eluting Stents after Acute Myocardial Infarction?

2012 ◽  
Vol 5 (suppl_1) ◽  
Author(s):  
Adeyemi Iyanoye ◽  
Sampada K Gandhi ◽  
Edith Zang ◽  
Javier Cabrera ◽  
Nora M Cosgrove ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Gender Difference ◽  
Stent Implantation ◽  
Gender Disparity ◽  
Coronary Stent ◽  
Single Type ◽  
Coronary Stent Implantation ◽  
Drug Eluting ◽  
To Receive

Background: Women are less likely than men to have cardiac catheterization and percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). It is unclear whether such gender disparity extends to the implantation of the type of coronary stent (bare metal stent (BMS) versus drug eluting stent (DES)) after AMI. Methods: We examined coronary stent implantation by type within 30 days of AMI in 33,748 patients admitted to non-federal hospitals in New Jersey using a statewide database. Data from 2003 through 2009 in the Myocardial Infarction Data Acquisition System (MIDAS) were used to identify patients with first episode of AMI and single type (BMS versus DES) of coronary stent implantation after the AMI. Multivariate logistic regression was used to analyze the differences by gender after adjustment for age, race, insurance, site of MI, pre-or post discharge stent implantation, and co-morbidities. Results: Coronary stent implantations after AMI were stratified by placement periods into: at index of AMI admission, n=16,719; within 2 days, n=22,019; within one week, n=31,618; and within 30 days of index AMI, n=33,748. In 2003, the use of BMS in women declined from 76% (386 of 507) to 68% (986 of 1454) from index AMI to 30 days, and in men from 79% (930 of 1181) to 70% (2017 of 2863). The use of DES in women increased from 24% (121 of 507) at index AMI to 32% (468 of 1454) at 30 days, and in men from 21% (251 of 1181) to 30% (846 of 2863). After adjustment for covariates, in 2003, women were more likely to receive DES than men within 2 days of the index AMI [Odds Ratio (OR): 1.37; 95% Confidence Interval (CI): (1.10, 1.70); p = 0.005], within 1 week of index AMI [OR: 1.21; CI (1.03,1.41); p= 0.02], within 30 days of index AMI [OR: 1.20; CI (1.03, 1.39); p = 0.02)]. In 2004 through 2009, both men and women had higher proportion of DES than BMS implantation after AMI. However, there was no significant gender difference in stent type for these years, except in 2006 when DES implants (received within 1 week and 30 days of index AMI) were significantly more frequent in women compared to men. Conclusion: Although women are less likely to receive PCI compared to men after AMI, there is generally no gender difference in the proportion of DES versus BMS received in contemporary years.

Technology Transfer

2011 ◽  
pp. 100-113
Author(s):  
Russ Lea
Keyword(s):  
Technology Transfer ◽  
Public Good ◽  
Public Funding ◽  
Arms Race ◽  
The Public ◽  
Economic Competitiveness ◽  
The Past ◽  
Private And Public ◽  
Technology Parks ◽  
Academic Earmarking

In the past three decades, economic competitiveness has morphed from an international concern (e.g. outcompete Japan) to a regional concern (e.g. knowledge clusters) to one where individual universities are in an “arms race” with each other for private and public funding (including licensing royalties, retaining star faculty, pursuing academic earmarking, developing technology parks and incubators, etc.). The greatest benefit that Bayh-Dole afforded universities, namely, to promote the utilization of their research for the public good, sometimes seems distant to the perceived objectives whereby universities attempt to maximize their own resources, including commercialization profits from faculty innovations that are ultimately transferred to the economy.

scholarly journals The Bioresorbable Drug-Eluting Coronary Stent

2017 ◽  
Vol 10 (8) ◽  
pp. 783-785
Author(s):  
Michael A. Kutcher
Keyword(s):  
Coronary Stent ◽  
Drug Eluting

scholarly journals Spontaneous Huge Subdural Spine Hematoma in a Patient Receiving Dual Anti-platelet Therapy after Drug-eluting Coronary Stent Implantation

2018 ◽  
Vol 54 (2) ◽  
pp. 131
Author(s):  
Xiongyi Han ◽  
Jumin Won ◽  
Doo Sun Sim ◽  
Min Chul Kim ◽  
Yongcheol Kim ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Coronary Stent ◽  
Anti Platelet Therapy ◽  
Coronary Stent Implantation ◽  
Drug Eluting

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

2015 ◽  
Vol 11 (5) ◽  
pp. 541-548 ◽  
Author(s):  
Emanuele Barbato ◽  
Sonja Salinger-Martinovic ◽  
Dragan Sagic ◽  
Branko Beleslin ◽  
Mathias Vrolix ◽  
...  
Keyword(s):  
Clinical Evaluation ◽  
Coronary Stent ◽  
New Drug ◽  
Stent System ◽  
Drug Eluting

AS-154 Mid-Term Outcomes of Pre-Dilation Using a New Scoring Balloon for Drug-Eluting Coronary Stent Implantation

2011 ◽  
Vol 107 (8) ◽  
pp. 44A
Author(s):  
Kenji Sadamatsu ◽  
Masataka Ikeda ◽  
Nobuhiro Honda ◽  
Yasuaki Koga ◽  
Kaori Oba ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Coronary Stent ◽  
Scoring Balloon ◽  
Coronary Stent Implantation ◽  
Drug Eluting ◽  
New Scoring
Sign in / Sign up

Export Citation Format

Share Document